News for Zymeworks Inc. (ZYME)

Zymeworks Inc. (NASDAQ:ZYME) Q4 2024 Earnings Conference Call March 5, 2025 4:30 PM ETCompany ParticipantsShrinal Inamdar - Director, Investor...

Zymeworks (ZYME) delivered earnings and revenue surprises of 3.12% and 15.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor-⍺ (FR⍺) and ZW171, a bispecific 2 + 1 T cel…

Zymeworks Inc (ZYME) is set to release its Q4 2024 earnings on Mar 5, 2025. The consensus estimate for Q4 2024 revenue is $45.20 million, and the earnings are e

**media[550677]**

VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline o…

VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. ( ZYME) a clinical-stage biotechnology company developing a diverse pipeline of

**media[549431]**

VANCOUVER, British Columbia, Feb. 25, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline …

Summary Zymeworks Inc (ZYME), a clinical-stage biotechnology company focused on developing innovative biotherapeutics for challenging diseases, announced the ap

VANCOUVER, British Columbia, Feb. 18, 2025 (GLOBE NEWSWIRE) —

On December 31, 2024, Redmile Group, LLC (Trades, Portfolio) executed a significant transaction involving Zymeworks Inc (ZYME), reducing its holdings by 261,448

VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. ( ZYME), a clinical-stage biotechnology company developing a diverse pipeline of

Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

**media[527926]**

Tuesday's Insider Trades: Key Buys and Sells in US Stocks Revealed

EcoR1 Capital buys $1.96 million in Zymeworks stock

Wednesday's Insider Activity: Top Buys and Sells in US Stocks

On January 15, 2025, EcoR1 Capital, LLC (Trades, Portfolio) executed a significant transaction involving Zymeworks Inc. The firm added 167,654 shares of Zymewor